Telemedicine and psoriasis: A review based on statements of the telemedicine working group of the International Psoriasis Council

El-Komy, Mohamed H.M.; Chiricozzi, Andrea; Kerkhof, Peter C M van de; Armstrong, April W.; Diamei, Vahid; Hsu, Christophe François; Gelfand, Joel M.; Navarini, Alexander A.

doi:10.1002/jvc2.93

Cited by 5 publications

(2 citation statements)

References 56 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…They showed that diagnoses of patients with PsO via TD were detected well comparable with FTF examination. A number of guidelines developed by dermatologists also provide some recommendations regarding the use of TD for PsO [18,19]. As a result, while TD has been reported to be a useful technique for the diagnosis of PsO, FTF examinations are still required in patients who may require skin biopsy.…”

Section: Discussionmentioning

confidence: 99%

Evaluation of the Diagnostic Accuracy of Teledermatology for Skin Lesions in Patients with Inflammatory Rheumatic Diseases

Artın,

Şahin,

Yazıcı

et al. 2024

Preprint

View full text Add to dashboard Cite

This study aimed to investigate the diagnostic accuracy and validity of teledermatology in patients with rheumatological diseases. The study included patients with inflammatory rheumatologic diseases who reported active skin and nail lesions during follow-up. A rheumatologist first evaluated each patient, and a preliminary diagnosis of the skin/nail lesion was recorded. Following, the images of the lesions were shared with two dermatologists and preliminary diagnoses were documented. The patients were then referred to a dermatologist for a face-to-face visit and a final diagnosis was made by using additional tests or skin biopsies if needed. After six months, the same images of the lesions were evaluated by one teledermatologist again, blind to the final diagnosis. The validity and reliability of teledermatology were assessed. Also the positive predictive values were calculated for the teledermatologists and rheumatologists. The study included 113 patients (female 75.2%, mean age: 44.9 years). The two teledermatologists were in perfect agreement; the rheumatologists were in substantial agreement with the final diagnosis (λ: 0.95, 0.82, and 0.61 respectively). The inter-rater agreements of two teledermatologists were as 0.80 (p = 0. 38); the intra-rater agreement of the one teledermatologist was as 0.90 (p = 0.29). Rheumatologists' positive predictive values for the most common lesions (psoriasis, leukocytoclastic vasculitis, and erythema nodosum) were shown to be lower than teledermatologists'. Teledermatology could be used in rheumatological patients with skin/nail lesions as a viable and reliable approach. When compared to teledermatologists, rheumatologists slightly underperformed in diagnosing the most common skin/nail lesions encountered in clinical practice.

show abstract

Section: Discussionmentioning

confidence: 99%

Evaluation of the Diagnostic Accuracy of Teledermatology for Skin Lesions in Patients with Inflammatory Rheumatic Diseases

Artın,

Şahin,

Yazıcı

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

“…Notably, telemedicine remains absent from existing (European) guidelines for psoriasis or atopic dermatitis ( 10 , 11 ). However, it gains more attention, and the International Psoriasis Council formulated a call to action, based on several statements concerning telemedicine ( 12 ). The objective of this systematic review is to quantitatively evaluate the efficacy and safety outcomes of telemedicine compared with in-person care for chronic inflammatory skin diseases.…”

mentioning

confidence: 99%

Is Telemedicine Suitable for Patients with Chronic Inflammatory Skin Conditions? A Systematic Review

Van Enst,

Weng,

Wanten

et al. 2024

Acta Derm Venereol

View full text Add to dashboard Cite

Telemedicine, the provision of remote healthcare, has gained prominence, accelerated by the COVID-19 pandemic. It has the potential to replace routine in-person follow-up visits for patients with chronic inflammatory skin conditions. However, it remains unclear whether telemedicine can effectively substitute in-person consultations for this patient group. This systematic review assessed the effectiveness and safety of telemedicine compared with traditional in-person care for chronic inflammatory skin diseases. A comprehensive search in various databases identified 11 articles, including 5 randomized controlled trials (RCTs) and 1 clinical controlled trial (CCT). These studies evaluated telemedicine’s impact on patients with psoriasis and atopic dermatitis, with varying methods like video consultations and digital platforms. The findings tentatively suggest that telemedicine does not seem to be inferior compared with in-person care, particularly in terms of condition severity and quality of life for patients with chronic inflammatory skin diseases. However, these results should be interpreted with caution due to the inherent uncertainties in the evidence. There are indications that telemedicine can offer benefits such as cost-effectiveness, time savings, and reduced travel distances, but it is important to recognize these findings as preliminary, necessitating further validation through more extensive research.

show abstract

Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic

Das

Chang

Paydar

et al. 2023

Dermatol Ther (Heidelb)

View full text Add to dashboard Cite

Introduction Limited access to healthcare during the COVID-19 pandemic prompted patients to seek care using telehealth. In this study, we assessed whether treatment patterns differed for patients with psoriasis (PsO) or psoriatic arthritis (PsA) initiating apremilast by either a telehealth or an in-person visit. Methods We estimated adherence and persistence among US patients in the Merative© MarketScan© Commercial and Supplemental Medicare Databases who newly initiated apremilast between April and June 2020, categorized by the type of visit (telehealth or in-person) when apremilast was first prescribed. Adherence was defined as the proportion of days covered (PDC), with PDC ≥ 0.80 considered to indicate high adherence. Persistence was defined as having apremilast available to take without a 60-day gap during follow-up. Factors associated with high adherence and persistence were estimated with logistic and Cox regression. Results Among apremilast initiators ( n = 505), the mean age was 47.6 years, 57.8% were female, and the majority had PsO (79.6%). Telehealth index visits were more likely among patients residing in Northeast USA (odds ratio [OR] 3.31, 95% confidence interval [CI] 1.63–6.71) and Western USA (OR 2.52, 95% CI 1.07–5.93]), those with a prescribing rheumatologist (OR 2.27, 95% CI 1.10–4.68), and those with any baseline telehealth visit (OR 1.91, 85% CI 1.20–3.04). Those initiating apremilast with a telehealth visit ( n = 141) had similar mean PDC to those initiating apremilast with an in-person visit ( n = 364) (0.695 vs. 0.728; p = 0.272). At the end of the 6-month follow-up, 54.3% of the overall population had high adherence (PDC ≥ 0.80) and 65.1% were persistent. After adjusting for potential confounders, patients initiating apremilast via telehealth had similar full adherence (OR 0.80, 95% CI 0.52–1.21) and persistence as those initiating apremilast in-person. Conclusion Patients with PsO and patients with PsA initiating apremilast via telehealth or in-person during the COVID-19 pandemic had similar medication adherence and persistence during the 6-month follow-up period. These data suggest that patients initiating apremilast can be as effectively managed with telehealth visits as with in-person visits. Supplementary Information The online version contains supplementary material available at 10.1007/s13555-023-00967-3.

show abstract

Telemedicine and psoriasis: A review based on statements of the telemedicine working group of the International Psoriasis Council

Cited by 5 publications

References 56 publications

Evaluation of the Diagnostic Accuracy of Teledermatology for Skin Lesions in Patients with Inflammatory Rheumatic Diseases

Evaluation of the Diagnostic Accuracy of Teledermatology for Skin Lesions in Patients with Inflammatory Rheumatic Diseases

Is Telemedicine Suitable for Patients with Chronic Inflammatory Skin Conditions? A Systematic Review

Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic

Contact Info

Product

Resources

About